Skip to main content
Erschienen in: Metabolic Brain Disease 7/2023

30.06.2023 | Original Article

Sequencing and Bioinformatics analysis of lncRNA/circRNA-miRNA-mRNA in Glioblastoma multiforme

verfasst von: Renjie Wang, Qi Li, Xiaolei Chu, Nan Li, Haiqian Liang, Feng He

Erschienen in: Metabolic Brain Disease | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Evidence suggests that non-coding RNAs have a role in glioblastoma multiforme (GBM), although the regulatory mechanisms controlled by competing endogenous RNAs (ceRNAs) in GBM are still poorly understood and infrequently described. This research extensively analyzed circRNA, lncRNA, miRNA, and mRNA expression changes in GBM patients. RNA-sequencing analyses were conducted to investigate differentially expressed genes (DEGs), lncRNAs (DELs), miRNAs (DEMs), and circRNAs (DECs) in the GBM. In this study, researchers found that GBM patients and healthy controls differed in the presence of 1224 DECs, 1406 DELs, 229 DEMs, and 2740 DEGs. PPI network analysis demonstrated that CEACAM5, CXCL17, FAM83A, TMPRSS4, and GGPRC5A were hub genes and enriched in modules. Then a ceRNA network was constructed with 8 circRNA, 7 lncRNAs, 16 miRNAs, and 17 mRNAs. Overall, the ceRNA interaction axes that were found may prove to be pivotal therapeutic targets for treating GBM.
Literatur
Zurück zum Zitat Abdul-Wahid A, Cydzik M, Fischer NW, Prodeus A, Shively JE, Martel A et al (2018) Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells. Int J Cancer 143:1963–1977CrossRefPubMedPubMedCentral Abdul-Wahid A, Cydzik M, Fischer NW, Prodeus A, Shively JE, Martel A et al (2018) Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells. Int J Cancer 143:1963–1977CrossRefPubMedPubMedCentral
Zurück zum Zitat Ambrosi C, Scribano D, Sarshar M, Zagaglia C, Singer BB, Palamara AT (2020) Acinetobacter baumannii targets Human Carcinoembryonic Antigen-Related cell adhesion molecules (CEACAMs) for Invasion of Pneumocytes. mSystems. ;5 Ambrosi C, Scribano D, Sarshar M, Zagaglia C, Singer BB, Palamara AT (2020) Acinetobacter baumannii targets Human Carcinoembryonic Antigen-Related cell adhesion molecules (CEACAMs) for Invasion of Pneumocytes. mSystems. ;5
Zurück zum Zitat Azari F, Kennedy GT, Chang A, Bernstein E, Nadeem B, Pèlegrin A et al (2022) Glycoprotein receptor CEACAM5-Targeted intraoperative Molecular Imaging Tracer in Non-Small Cell Lung Cancer. The Annals of thoracic surgery Azari F, Kennedy GT, Chang A, Bernstein E, Nadeem B, Pèlegrin A et al (2022) Glycoprotein receptor CEACAM5-Targeted intraoperative Molecular Imaging Tracer in Non-Small Cell Lung Cancer. The Annals of thoracic surgery
Zurück zum Zitat Baek DS, Kim YJ, Vergara S, Conard A, Adams C, Calero G et al (2022) A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo. Cancer Lett 525:97–107CrossRefPubMed Baek DS, Kim YJ, Vergara S, Conard A, Adams C, Calero G et al (2022) A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo. Cancer Lett 525:97–107CrossRefPubMed
Zurück zum Zitat Basso J, Paggi MG, Fortuna A, Vitorino C (2022) Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma. 297:507–521 Basso J, Paggi MG, Fortuna A, Vitorino C (2022) Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma. 297:507–521
Zurück zum Zitat Cheng J, Meng J, Zhu L, Peng Y (2020) Exosomal non-coding RNAs in glioma: biological functions and potential clinical applications. Mol Cancer 19:66CrossRefPubMedPubMedCentral Cheng J, Meng J, Zhu L, Peng Y (2020) Exosomal non-coding RNAs in glioma: biological functions and potential clinical applications. Mol Cancer 19:66CrossRefPubMedPubMedCentral
Zurück zum Zitat Choreño-Parra JA, Thirunavukkarasu S, Zúñiga J, Khader SA (2020) The protective and pathogenic roles of CXCL17 in human health and disease: potential in respiratory medicine. Cytokine Growth Factor Rev 53:53–62CrossRefPubMedPubMedCentral Choreño-Parra JA, Thirunavukkarasu S, Zúñiga J, Khader SA (2020) The protective and pathogenic roles of CXCL17 in human health and disease: potential in respiratory medicine. Cytokine Growth Factor Rev 53:53–62CrossRefPubMedPubMedCentral
Zurück zum Zitat Gisina A, Novikova S, Kim Y, Sidorov D, Bykasov S, Volchenko N et al (2021) CEACAM5 overexpression is a reliable characteristic of CD133-positive colorectal cancer stem cells. Cancer Biomark A 32:85–98CrossRef Gisina A, Novikova S, Kim Y, Sidorov D, Bykasov S, Volchenko N et al (2021) CEACAM5 overexpression is a reliable characteristic of CD133-positive colorectal cancer stem cells. Cancer Biomark A 32:85–98CrossRef
Zurück zum Zitat Guo X, Piao H (2021) Research Progress of circRNAs in Glioblastoma. Front cell Dev biology 9:791892CrossRef Guo X, Piao H (2021) Research Progress of circRNAs in Glioblastoma. Front cell Dev biology 9:791892CrossRef
Zurück zum Zitat Holmer R, Wätzig GH, Tiwari S, Rose-John S, Kalthoff H (2015) Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells. BMC Cancer 15:975CrossRefPubMedPubMedCentral Holmer R, Wätzig GH, Tiwari S, Rose-John S, Kalthoff H (2015) Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells. BMC Cancer 15:975CrossRefPubMedPubMedCentral
Zurück zum Zitat Ji H, Song H, Wang Z, Jiao P, Xu J, Li X et al (2021) FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma. 19:423 Ji H, Song H, Wang Z, Jiao P, Xu J, Li X et al (2021) FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma. 19:423
Zurück zum Zitat Jia B, Liu W, Gu J, Wang J, Lv W, Zhang W et al (2019) MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1. Exp Cell Res 375:73–81CrossRefPubMed Jia B, Liu W, Gu J, Wang J, Lv W, Zhang W et al (2019) MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1. Exp Cell Res 375:73–81CrossRefPubMed
Zurück zum Zitat Kelleher M, Singh R, O’Driscoll CM, Melgar S (2019) Carcinoembryonic antigen (CEACAM) family members and inflammatory bowel disease. Cytokine Growth Factor Rev 47:21–31CrossRefPubMed Kelleher M, Singh R, O’Driscoll CM, Melgar S (2019) Carcinoembryonic antigen (CEACAM) family members and inflammatory bowel disease. Cytokine Growth Factor Rev 47:21–31CrossRefPubMed
Zurück zum Zitat Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P et al (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896CrossRefPubMed Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P et al (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896CrossRefPubMed
Zurück zum Zitat Li L, Ji Y, Chen Y, Zhen Z (2021) MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma. Cytokine 141:155436CrossRefPubMed Li L, Ji Y, Chen Y, Zhen Z (2021) MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma. Cytokine 141:155436CrossRefPubMed
Zurück zum Zitat Liu R, Dai W (2021) CircCDC45 promotes the malignant progression of glioblastoma by modulating the miR-485-5p/CSF-1 axis. 21:1090 Liu R, Dai W (2021) CircCDC45 promotes the malignant progression of glioblastoma by modulating the miR-485-5p/CSF-1 axis. 21:1090
Zurück zum Zitat Ma R, Taphoorn MJB, Plaha P (2021) Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry 92:1103–1111CrossRefPubMed Ma R, Taphoorn MJB, Plaha P (2021) Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry 92:1103–1111CrossRefPubMed
Zurück zum Zitat Ohba S, Hirose Y (2016) Current and future drug treatments for glioblastomas. Curr Med Chem 23:4309–4316CrossRefPubMed Ohba S, Hirose Y (2016) Current and future drug treatments for glioblastomas. Curr Med Chem 23:4309–4316CrossRefPubMed
Zurück zum Zitat Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin cancer research: official J Am Association Cancer Res 19:764–772CrossRef Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin cancer research: official J Am Association Cancer Res 19:764–772CrossRef
Zurück zum Zitat Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850CrossRefPubMed Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850CrossRefPubMed
Zurück zum Zitat Powell E, Shao J, Picon HM, Bristow C, Ge Z, Peoples M et al (2018) A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis. NPJ breast cancer 4:9CrossRefPubMedPubMedCentral Powell E, Shao J, Picon HM, Bristow C, Ge Z, Peoples M et al (2018) A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis. NPJ breast cancer 4:9CrossRefPubMedPubMedCentral
Zurück zum Zitat Robin AM, Lee I, Kalkanis SN (2017) Reoperation for recurrent Glioblastoma Multiforme. Neurosurg Clin North Am 28:407–428CrossRef Robin AM, Lee I, Kalkanis SN (2017) Reoperation for recurrent Glioblastoma Multiforme. Neurosurg Clin North Am 28:407–428CrossRef
Zurück zum Zitat Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S et al (2016) MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 5:1917–1946CrossRefPubMedPubMedCentral Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S et al (2016) MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 5:1917–1946CrossRefPubMedPubMedCentral
Zurück zum Zitat Simpson L, Galanis E (2006) Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates. Expert Rev Anticancer Ther 6:1593–1607CrossRefPubMed Simpson L, Galanis E (2006) Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates. Expert Rev Anticancer Ther 6:1593–1607CrossRefPubMed
Zurück zum Zitat Wang Y, Xu R, Zhang D, Lu T, Yu W, Wo Y et al (2019) Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting mir-330-5p to promote non-small cell lung cancer progression. Translational lung cancer research 8:862–875CrossRefPubMedPubMedCentral Wang Y, Xu R, Zhang D, Lu T, Yu W, Wo Y et al (2019) Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting mir-330-5p to promote non-small cell lung cancer progression. Translational lung cancer research 8:862–875CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhang F, Jin Liu X, Qu X, Sheng Hu Z, Yang YM, Ma L et al (2012) Osteopontin’s colocalization with the adhesion molecule CEACAM5 in cytoplasm of carcinoma of tongue and its correlation with the invasion of that diease. Cancer Cell Int 12:33CrossRefPubMedPubMedCentral Zhang F, Jin Liu X, Qu X, Sheng Hu Z, Yang YM, Ma L et al (2012) Osteopontin’s colocalization with the adhesion molecule CEACAM5 in cytoplasm of carcinoma of tongue and its correlation with the invasion of that diease. Cancer Cell Int 12:33CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei P et al (2018) A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. 9:4475 Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei P et al (2018) A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. 9:4475
Zurück zum Zitat Zhang X, Niu W, Mu M, Hu S, Niu C (2020) Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop. Journal of experimental & clinical cancer research: CR. ;39:196 Zhang X, Niu W, Mu M, Hu S, Niu C (2020) Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop. Journal of experimental & clinical cancer research: CR. ;39:196
Zurück zum Zitat Zhao C, Guo R, Guan F (2020) MicroRNA-128-3p enhances the chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. 10:9471 Zhao C, Guo R, Guan F (2020) MicroRNA-128-3p enhances the chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. 10:9471
Zurück zum Zitat Zhou J, Fan X, Chen N, Zhou F, Dong J, Nie Y et al (2015) Identification of CEACAM5 as a biomarker for prewarning and prognosis in gastric Cancer. J Histochem cytochemistry: official J Histochem Soc 63:922–930CrossRef Zhou J, Fan X, Chen N, Zhou F, Dong J, Nie Y et al (2015) Identification of CEACAM5 as a biomarker for prewarning and prognosis in gastric Cancer. J Histochem cytochemistry: official J Histochem Soc 63:922–930CrossRef
Metadaten
Titel
Sequencing and Bioinformatics analysis of lncRNA/circRNA-miRNA-mRNA in Glioblastoma multiforme
verfasst von
Renjie Wang
Qi Li
Xiaolei Chu
Nan Li
Haiqian Liang
Feng He
Publikationsdatum
30.06.2023
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 7/2023
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-023-01256-w

Weitere Artikel der Ausgabe 7/2023

Metabolic Brain Disease 7/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.